Pharma Cross Private Limited - Due diligence report
A 360° intelligence report on Pharma Cross Private Limited: trust score, financial health, credit view, compliance, directors, growth and di…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Pharma Cross Private Limited — 360° Intelligence Report
Generated from MCA filings & public recordsPharma Cross Private Limited is assessed as Moderate with a Trust Score of 71/100. Pharma Cross Private Limited is an active private limited indian non-government company incorporated in 1998, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 23 Jul 2026 from the latest processed filings. Pharma Cross Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- Open charges exceed net worth - secured lenders rank ahead.
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
Charges position: 2 open (9.60 cr) · 0 satisfied (-).
| Lender | Charges | Amount |
|---|---|---|
| Others | 2 | 48.0 cr |
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2021 - filings overdue.
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| DEEPAK KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRADIP BHARDWAJ | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- PRADIP BHARDWAJ has DIN status "Disqualified by RoC u/s 164(2)".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
As per FY 2020 annual returnPromoters hold a minority stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 50 · Distress 80Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- 2 open charge(s) of 9.60 cr already registered.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management churn warrants questions.
MCA Filings & Events Timeline
Latest 9 eventsKey Observations
Auto-generated from the data aboveWho Uses This Report
CA · CS · Banker · Investor · VendorVerify Pharma Cross Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Pharma Cross Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Pharma Cross Private Limited - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 71/100, distress signals and MSME payment-delay disclosures - know whether Pharma Cross Private Limited pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Pharma Cross Private Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Pharma Cross Private Limited an active company?
Pharma Cross Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Pharma Cross Private Limited financially healthy?
Pharma Cross Private Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.
Should I do business with Pharma Cross Private Limited?
Its overall Trust Score is 71/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Pharma Cross Private Limited?
Promoters hold a minority stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Pharma Cross Private Limited have loans or charges against its assets?
2 open charge(s) are registered against its assets.
Is Pharma Cross Private Limited up to date with its ROC filings?
Last balance sheet is for Mar 2021 - filings overdue. Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Pharma Cross Private Limited?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.